AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AGIOS PHARMACEUTICALS, INC. Director's Dealing 2017

May 31, 2017

31580_dirs_2017-05-31_e5222d37-b4a3-406e-b0c7-e37e73026eee.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2017-05-27

Reporting Person: Scadden David (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	371	Direct